Mechanism of metabolic activation of the analgetic bucetin to bacterial mutagens by hamster liver microsomes. 1985

T Nohmi, and M Ishidate, and A Hiratsuka, and T Watabe

UI MeSH Term Description Entries
D008297 Male Males
D008647 Mesocricetus A genus in the order Rodentia and family Cricetidae. One species, Mesocricetus auratus or golden hamster is widely used in biomedical research. Hamsters, Golden,Hamsters, Golden Syrian,Hamsters, Syrian,Mesocricetus auratus,Syrian Golden Hamster,Syrian Hamster,Golden Hamster,Golden Hamster, Syrian,Golden Hamsters,Golden Syrian Hamsters,Hamster, Golden,Hamster, Syrian,Hamster, Syrian Golden,Syrian Hamsters
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D010628 Phenetidine Used in the manufacture of acetophenetidin. Aminophenetole,Ethoxyaniline
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D000627 Aminophenols Phenols substituted in any position by an amino group. Hydroxyanilines
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species

Related Publications

T Nohmi, and M Ishidate, and A Hiratsuka, and T Watabe
December 1980, Biochemical pharmacology,
T Nohmi, and M Ishidate, and A Hiratsuka, and T Watabe
February 1978, Biochemical pharmacology,
T Nohmi, and M Ishidate, and A Hiratsuka, and T Watabe
January 1984, Mutation research,
T Nohmi, and M Ishidate, and A Hiratsuka, and T Watabe
January 1957, Canadian journal of biochemistry and physiology,
T Nohmi, and M Ishidate, and A Hiratsuka, and T Watabe
August 1987, Biochemical pharmacology,
T Nohmi, and M Ishidate, and A Hiratsuka, and T Watabe
May 1978, Biochemical and biophysical research communications,
T Nohmi, and M Ishidate, and A Hiratsuka, and T Watabe
January 1980, Cancer research,
T Nohmi, and M Ishidate, and A Hiratsuka, and T Watabe
June 1982, Biochemical pharmacology,
T Nohmi, and M Ishidate, and A Hiratsuka, and T Watabe
November 1977, Mutation research,
Copied contents to your clipboard!